Advance Agrolife IPO Opens Tomorrow at ₹192.86 Crore; Strong Revenue Growth and Expanding Market Presence Highlight Company Strengths

Jaipur, 29 September 2025: Agrochemical firm Advance Agrolife Limited is set to launch its Initial Public Offering (IPO) for subscription on 30 September 2025, with the three-day issue closing on 3 October 2025. Advance Agrolife IPO, sized at ₹192.86 crore, will see shares listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on 8 October 2025.

Founded in 2002 and headquartered in Jaipur, Advance Agrolife Limited is an Indian agrochemical company specialising in sustainable crop protection solutions. With robust R&D capabilities, integrated manufacturing, and a wide distribution network, the firm aims to strengthen its foothold in domestic and international markets while focusing on product innovation and operational efficiency.

Advance Agrolife IPO Details: Price Band ₹95-₹100, Lot Size 150 Shares, Issue Size ₹192.86 Crore

The company has set a price range of ₹95-₹100 per share, with a lot size of 150 shares, amounting to approximately ₹15,000 at the upper band. The IPO comprises a fresh issue of 1.93 crore equity shares, with no Offer for Sale (OFS). Allotment will be finalised on 6 October 2025, followed by share credit or refunds on 7 October 2025. Choice Capital Advisors Pvt Ltd is managing the issue, while KFin Technologies Ltd is the registrar.

Advance Agrolife IPO Revenue and Profit Surge: Net Profit Climbs 72% Over Two Years to ₹256.4 Million in FY25

Advance Agrolife’s financial performance indicates a steady revenue growth, with operations rising from ₹3,978.1 million in FY23 to ₹5,022.6 million in FY25, representing a three-year CAGR of 12.3%. Net profit improved from ₹148.7 million in FY23 to ₹256.4 million in FY25, while net worth surged from ₹506.0 million to ₹1,008.7 million over the same period.

Earnings per share (EPS) also increased to ₹5.70 in FY25, up from ₹3.30 in FY23, and net asset value (NAV) per share grew to ₹22.42 from ₹11.24, reflecting consistent financial stability. Total borrowings rose to ₹804.5 million in FY25, indicating investment in business expansion and working capital.

Advance Agrolife IPO Diverse Product Portfolio and Manufacturing Backbone Drive Market Reach Across 19 States and Seven Export Countries

Advance Agrolife holds over 410 product registrations, spanning insecticides, herbicides, fungicides, and plant growth regulators. Integrated manufacturing facilities in Jaipur enable production of both technical and formulation grade chemicals, ensuring backward integration and cost efficiencies. The company has established a strong domestic presence across 19 states and exports to seven countries, including the UAE, Bangladesh, China, and Turkey. Experienced promoters with over 20 years in agrochemicals are leading these initiatives.

Advance Agrolife IPO Customer and Regulatory Challenges Present Key Risks to Operations

The company faces a degree of customer concentration, with the top ten clients contributing 69% of FY25 revenues. Regulatory scrutiny is another challenge, as 14 pesticides contributing around 20% of revenues are under a proposed ban. High working capital needs are reflected in extended trade receivable days of 111 in FY25, up from 78 in FY23. Geographic concentration in northern and central agricultural states, coupled with pending litigation relating to misbranding under the Insecticides Act, adds operational risk.

Advance Agrolife’s strong revenue growth, diversified product portfolio, and integrated manufacturing provide a robust framework for business operations, while regulatory scrutiny, high client concentration, and regional reliance highlight areas requiring careful monitoring for operational continuity and risk management.

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations